Myelodysplastic SyndromesLeukemia, Lymphocytic, Chronic, B-CellLeukemia, LymphoidPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemiaSurvival RateLeukemia, Myeloid, AcuteBone MarrowPrognosisAnemia, RefractoryLeukemia, B-CellSurvival AnalysisAnemia, Refractory, with Excess of BlastsVidarabineLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTreatment OutcomeCell SurvivalAsparaginaseLeukemic InfiltrationAntineoplastic AgentsRemission InductionCytarabineLeukemia, T-CellAntineoplastic Combined Chemotherapy ProtocolsLeukemia, MyeloidMethotrexatePrecursor B-Cell Lymphoblastic Leukemia-LymphomaB-LymphocytesKaryotypingVincristineDisease-Free SurvivalLeukemia, Biphenotypic, AcuteGene Expression Regulation, LeukemicChromosome AberrationsRemission, SpontaneousLymphocytes, NullLeukemia, Myelomonocytic, Chronic6-MercaptopurineAcute DiseaseImmunoglobulin Heavy ChainsLeukemia, ExperimentalLeukemia-Lymphoma, Adult T-CellRetrospective StudiesLymphomaChlorambucilTime FactorsRecurrenceBlast CrisisReceptors, Antigen, B-CellCyclophosphamideBurkitt LymphomaZAP-70 Protein-Tyrosine KinaseDNA, NeoplasmTranslocation, GeneticLeukemia, Hairy CellRosette FormationChromosomes, Human, 6-12 and XMutationPhiladelphia ChromosomeAnisocoriaBone Marrow TransplantationTransplantation, HomologousAntibodies, MonoclonalTumor Cells, CulturedFlow CytometryApoptosisLymphocytesCladribineT-LymphocytesCorneal PerforationKaplan-Meier EstimateDrug Administration ScheduleFollow-Up StudiesPrednisoneNeoplasm ProteinsChromosomes, Human, Pair 5Antigens, NeoplasmCytogenetic AnalysisLeukemia Virus, MurineSurvivalAntigens, CD38Drug Resistance, NeoplasmPreleukemiaImmunophenotypingAntigens, CD5AzacitidineFusion Proteins, bcr-ablDaunorubicinDNA NucleotidylexotransferaseNeoplasm StagingRisk FactorsGraft SurvivalHematologic NeoplasmsThalidomideSalvage TherapyBase SequenceAnemia, SideroblasticCombined Modality TherapyMyeloproliferative DisordersHematopoietic Stem Cells